European Molecular Biology Organisation (Embo) and Nature Publishing announce that from January 2007 the Embo Journal and Embo reports will accept open access articles, subject to a publication fee
The journal is moving to a mixed-revenue model of subscription charges and publication fees.
The open access option will be available to all authors submitting original research on or after 1 January 2007.
The publication fee will be euro2000+VAT (where applicable).
Articles published with a publication fee will be clearly identified in the online and print editions of the journal with an Embo Open logo.
Print subscription prices will not be affected.
Site license prices will be adjusted in line with the amount of subscription-content published annually.
Editors will be blind to the author's choice, avoiding any possibility of a conflict of interest during through peer review and acceptance.
Authors paying the publication fee will be entitled to self-archive the published version immediately on publication, in the repositories of their choice, and in any format.
Content that an author has decided to make freely available online will be licensed under the Creative Commons Deed 2.5.
The author will thereby permit dissemination and reuse of the article, and so will enable the sharing and reuse of scientific material.
It does not however permit commercial exploitation or the creation of derivative works without specific permission.
Other articles will continue to be published under NPG's exclusive License-to-Publish, where NPG's usual self-archiving policy will apply.
Original research published in Molecular Systems Biology, the open access journal published by EMBO and NPG will also be offered under the Creative Commons Deed 2.5 as of January 2007.
The Embo Journal and Embo reports are published by NPG on behalf of Embo.
NPG publishes the open access title Molecular Systems Biology in partnership with Embo, and subscription journals such as Nature and Nature Cell Biology, as well as other society-owned titles such as Kidney International and Journal of Investigative Dermatology.
